Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Has Average Target Price of $498.83

Intuitive Surgical, Inc. (NASDAQ:ISRG) has received a consensus recommendation of “Moderate Buy” from the thirty-one research firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation, twenty-two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $498.83.

A number of brokerages recently commented on ISRG. Stifel Nicolaus lowered their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research note on Friday, July 17th. Raymond James Financial restated an “outperform” rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. UBS Group restated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday. Citigroup reduced their price objective on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Finally, Wells Fargo & Company reissued an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th.

Insider Buying and Selling

In related news, EVP Mark Brosius sold 77 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the transaction, the executive vice president owned 881 shares of the company’s stock, valued at $330,877.17. This trade represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of the business’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total value of $407,765.16. Following the completion of the transaction, the vice president owned 1,026 shares in the company, valued at $384,175.44. This trade represents a 51.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,370 shares of company stock valued at $4,891,989 in the last quarter. Corporate insiders own 0.60% of the company’s stock.

Institutional Trading of Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in ISRG. Eagle Strategies LLC raised its position in Intuitive Surgical by 4.8% during the 3rd quarter. Eagle Strategies LLC now owns 832 shares of the medical equipment provider’s stock worth $338,000 after buying an additional 38 shares during the last quarter. St. Louis Financial Planners Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 3rd quarter worth $3,098,000. TD Waterhouse Canada Inc. boosted its holdings in shares of Intuitive Surgical by 15.9% in the third quarter. TD Waterhouse Canada Inc. now owns 39,455 shares of the medical equipment provider’s stock valued at $15,822,000 after acquiring an additional 5,422 shares in the last quarter. KFG Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 3.2% in the third quarter. KFG Wealth Management LLC now owns 978 shares of the medical equipment provider’s stock valued at $398,000 after acquiring an additional 30 shares in the last quarter. Finally, James T. Borello RIA boosted its holdings in shares of Intuitive Surgical by 63.1% in the third quarter. James T. Borello RIA now owns 106 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 41 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts at Erste Group Bank raised their earnings estimates for ISRG, suggesting improved expectations for the company’s upcoming results and longer-term profitability. Erste Group Bank Analysts Boost Earnings Estimates for ISRG
• Positive Sentiment: Recent results have shown double-digit growth in robotic-surgery procedures, revenue and Intuitive Surgical’s installed base of systems. That underlying operating momentum remains a key support for the investment case despite the stock’s broader underperformance this year. Intuitive Surgical Valuation and Growth
• Positive Sentiment: The shares increased in the prior session and outperformed the broader market that day, reflecting some investor support ahead of the earnings release. ISRG Beats Stock Market Upswing
• Neutral Sentiment: Investors are focused on third-quarter procedure growth, da Vinci system demand, revenue, margins and other operating metrics—not just earnings per share and revenue—to determine whether recent momentum is sustainable. ISRG Ahead of Q3 Earnings
• Negative Sentiment: Expectations are tempered by slowing U.S. procedure growth and headwinds in China. These issues could pressure system placements and margins, increasing the risk of an earnings-related market reaction. ISRG Q3 Earnings Preview
• Negative Sentiment: Despite double-digit growth, shares have declined substantially during 2026 and trade at a premium valuation. Investors are questioning whether a valuation around 33 times expected earnings adequately reflects the company’s growth prospects, particularly if procedure growth slows. ISRG Valuation Analysis

Intuitive Surgical Stock Down 0.3%

NASDAQ ISRG opened at $426.70 on Wednesday. Intuitive Surgical has a 52 week low of $328.57 and a 52 week high of $603.88. The stock has a market capitalization of $150.74 billion, a PE ratio of 51.24, a price-to-earnings-growth ratio of 3.23 and a beta of 1.46. The firm has a 50 day moving average of $391.43 and a two-hundred day moving average of $409.74.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The company had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.81 EPS. On average, equities research analysts expect that Intuitive Surgical will post 8.87 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.